Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Recruiting
Checked: April 17, 2026 at 2:08 AM UTC
| NCT Number | NCT06158841 |
| Recruiting Status | Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 380 participants |
| Active Locations | 44 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | March 13, 2026 (Mar 13, 2026) |
As of April 17, 2026: Clinical trial NCT06158841 is currently recruiting participants. This clinical trial study for multiple myeloma is actively seeking new participants at 44 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06158841 is actively recruiting participants as of April 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 44 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06158841 was last updated Mar 13, 2026 (March 13, 2026). HelloStudys verifies this status automatically.